VOYA Investment Management
AVBP icon

VOYA Investment Management’s ArriVent BioPharma AVBP Stock Holding History

VOYA Investment Management’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$354K Buy
+15,331
New +$346K ﹤0.01% 1877
2025
Q1 		– Sell
-8,373
Closed -$223K – 2736
2024
Q4 		$223K Buy
+8,373
New +$240K ﹤0.01% 2345

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VOYA Investment Management's AVBP Position: Q1 2026 in Review

VOYA Investment Management opened a new position in ArriVent BioPharma (AVBP) in Q1 2026: 15,331 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #1877 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in AVBP as recently as Q4 2024.

VOYA Investment Management first reported a position in AVBP in Q4 2024 and has held it in 2 quarters since. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • VOYA Investment Management held 15,331 shares of ArriVent BioPharma worth $354K as of Q1 2026.
  • ArriVent BioPharma was a new VOYA Investment Management position in Q1 2026.
  • ArriVent BioPharma made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1877 holding.
  • VOYA Investment Management first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 2 quarters since.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.